Vyjuvek

Last Updated: 02/24/2026

Need to find the closest trial?

Sort By Distance

Save trials for later

Not sure about your diagnosis?

Check Your Symptoms

1 clinical trial found

Sort by:

Targeting Collagen VII Antibodies With IV IgG in Dystrophic Epidermolysis Bullosa

Enrollment Status: Recruiting

Publish Date: August 06, 2025

Intervention Type: Biological

Study Phase: Phase 1/Phase 2

Summary: The study objective is to see if IV IgG treatment in Recessive Dystrophic Epidermolysis Bullosa (RDEB) skin in conjunction with VYJUVEK treatment improves wound healing and affects the levels of C7 and HSV-1 antibody levels in serum. Fewer wounds, more rapidly healing wounds, and decreased C7 and HSV-1 antibodies could improve quality of life.

Showing 1-1 of 1

Last Updated: 02/24/2026